Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VPS13C divergent transcript (VPS13C-DT) is a non-coding RNA gene found adjacent to the VPS13C protein-coding gene. Divergent transcripts are generally transcribed in the opposite direction relative to an adjacent (often protein-coding) gene, forming a head-to-head sense/antisense gene pair. While protein-coding VPS13C plays a critical role in lipid transfer between the endoplasmic reticulum and late endosome/lysosome, participates in mitochondrial homeostasis, and is genetically linked to familial and sporadic Parkinson’s disease, the specific functions of VPS13C-DT are not well annotated. It is primarily referred to as an RNA transcript with no evidence of translation into a protein or direct involvement as a drug target, receptor, enzyme, transporter, or similar molecular class. As such, it does not fulfill criteria for a "target" for therapeutic intervention. The presence of "divergent transcript" in a gene name usually indicates a transcript of unknown or regulatory function rather than a protein-coding gene or established drug target. Key distinction: Do not confuse VPS13C-DT (a non-coding RNA) with intracellular lipid transporter VPS13C, which is a well-characterized protein involved in Parkinson’s disease and is under investigation as a disease-relevant protein target. No evidence in the literature describes VPS13C-DT as a direct therapeutic target, and its role, if any, in molecular pathology or as a biomarker remains undefined. If structured target information is required, use the protein "Vacuolar protein sorting 13 homolog C (VPS13C)", but not "VPS13C divergent transcript" or "VPS13C-DT" for therapeutic target purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on VPS13C divergent transcript (VPS13C-DT).